Literature DB >> 23237439

[The role of transforming growth factor-β in the pathogenesis of mitral valve prolapse].

E G Malev, E V Zemtsovskiĭ, M Iu Omel'chenko, L V Vasina.   

Abstract

Changes in activity of the components of TGF-β signaling pathway is associated with inherited disorders of connective tissue such as Marfan syndrome, Loeys-Dietz syndrome, etc. However, its impact on mitral valve prolapse (MVP) has not been completely studied. We examined 35 patients undergoing reconstructive surgery due MVP complicated by severe mitral insufficiency (mean age 62.5+/-7.9 years, 46% - men). High level of TGF-βl/2 was detected in majority (65%) of cases and correlated with the thickness of posterior leaflet (r=0.67; p=0.016), residual valve prolapse (r=0.68; p=0.007) and residual mitral regurgitation (MR) (r=0.56; p=0.01). In patients with high TGF-βl/2 level we detected a significant decrease in left ventricular longitudinal systolic (-13.5+/-2.2% vs. -16.6+/-2.3%, p=0.008) and diastolic (1.14+/-0.20 s-1 vs. 1.34+/-0.18 s-1, p=0.04) strain and SR (-0.89+/-0.15 s-1 vs. -1.14+/-0.15 s-1, p=0.002). Thus, TGF-β has a significant impact on the progression of valve myxomatous degeneration. The high activity of TGF-β signaling pathway results also in reduction in LV function, probably due to the profibrotic activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23237439

Source DB:  PubMed          Journal:  Kardiologiia        ISSN: 0022-9040            Impact factor:   0.395


  2 in total

1.  Increased Infiltration of Extra-Cardiac Cells in Myxomatous Valve Disease.

Authors:  Kimberly Sauls; Katelynn Toomer; Katherine Williams; Amanda J Johnson; Roger R Markwald; Zoltan Hajdu; Russell A Norris
Journal:  J Cardiovasc Dev Dis       Date:  2015-07-24

Review 2.  Mechanistic insights of the left ventricle structure and fibrosis in the arrhythmogenic mitral valve prolapse.

Authors:  Leticia Fernández-Friera; Rafael Salguero; Luca Vannini; Ana Fidalgo Argüelles; Fernando Arribas; Jorge Solís
Journal:  Glob Cardiol Sci Pract       Date:  2018-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.